It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-009.mrc:85534910:4846
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:85534910:4846?format=raw

LEADER: 04846mam a2200361 a 4500
001 4066209
005 20221027030510.0
008 001005t20022002njua b 001 0 eng
010 $a 00050029
016 7 $a100966522$2DNLM
020 $a089603464X (alk. paper)
035 $a(OCoLC)ocm45167221
035 $9ATW8905HS
035 $a4066209
040 $aNLM$cNLM$dNNC-M$dOrLoB-B
042 $apcc
060 00 $a2001 M-032
060 10 $aWG 500$bN5324 2002
245 04 $aThe new angiotherapy /$cedited by Tai-Ping D. Fan and Elise C. Kohn ; foreword by Judah Folkman.
260 $aTotowa, N.J. :$bHumana Press,$c[2002], ©2002.
300 $axix, 609 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $gI.$tConcepts.$g1.$tVasculogenesis and Angiogenesis /$rRobert Auerbach and Wanda Auerbach.$g2.$tAngiogenesis-Regulating Cytokines /$rMichael S. Pepper, Stefano J. Mandriota and Roberto Montesano.$g3.$tThe Angiopoietins /$rPamela F. Jones.$g4.$tRegulation of Vascular Morphogenesis by Extracellular Matrix Proteins /$rAmy D. Bradshaw and E. Helene Sage --$gII.$tAngiogenesis in Health and Disease.$g5.$tIntegrin Receptors and the Regulation of Angiogenesis /$rDorothy Rodriguez and Peter C. Brooks.$g6.$tVasoactive Peptides in Angiogenesis /$rDavid Andrew Walsh and Tai-Ping D. Fan.$g7.$tAngiogenesis in Wound Healing and Surgery /$rWayne A. Morrison, Geraldine M. Mitchell and Jane E. Barker /$r[et al.].$g8.$tAngiogenesis and Vascular Endothelial Growth Factor (VEGF) in Reproduction /$rD. Stephen Charnock-Jones, Yulong He and Stephen K. Smith.$g9.$tRheumatoid Arthritis: A Target for Anti-Angiogenic Therapy? /$rEwa M. Paleolog and Jadwiga M. Miotla.
505 80 $g10.$tDiagnostic and Prognostic Significance of Tumor Angiogenesis /$rStephen B. Fox and Adrian L. Harris --$gIII.$tStimulation of Angiogenesis [Therapeutic Angiogenesis].$g11.$tHyaluronan Oligosaccharides Promote Wound Repair: Its Size-Dependent Regulation of Angiogenesis /$rDavid C. West and Tai-Ping D. Fan.$g12.$tRole of Thymic Peptides in Wound Healing /$rHynda K. Kleinman, Derrick S. Grant and Katherine M. Malinda.$g13.$tAngiogenesis and Growth Factors in Ulcer Healing /$rSandor Szabo, Yuen Shing and M. Judah Folkman /$r[et al.].$g14.$tAngiogenesis in Skeletal and Cardiac Muscle: Role of Mechanical Factors /$rMargaret D. Brown and Olga Hudlicka.$g15.$tTherapeutic Angiogenesis for the Treatment of Cardiovascular Disease /$rJeffrey M. Isner and Takayaki Asahara.$g16.$tTherapeutic Angiogenesis for the Heart /$rJohannes Waltenberger and Vinzenz Hombach.$g17.$tContact-Guided Angiogenesis and Tissue Engineering /$rRobert A. Brown, Giorgio Terenghi and Clive D. McFarland --$gIV.$tAnti-Angiogenesis.
505 80 $g18.$tInhibitors of Matrix Metalloproteinases /$rPeter D. Brown and William G. Stetler-Stevenson.$g19.$tControl of Angiogenesis by Microbial Products /$rTsutomu Oikawa.$g20.$tInteraction of Angiogenic Growth Factors with Endothelial Cell Heparan Sulfate Proteoglycans: Implications for the Development of Angiostatic Compounds /$rMarco Rusnati, Giovanni Tulipano and Marco Presta.$g21.$t2-Methoxyestradiol: A Novel Endogenous Chemotherapeutic and Anti-Angiogenic Agent /$rVictor S. Pribluda, Theresa M. LaVallee and Shawn J. Green --$gV.$tNovel Targets.$g22.$tReceptor Tyrosine Kinases in Angiogenesis /$rLaura K. Shawver, Kenneth E. Lipson and T. Annie T. Fong /$r[et al.].$g23.$tTargeting Gene Therapy to the Tumor Vasculature /$rKelvin K. W. Lau and Roy Bicknell.$g24.$tAntibody Targeting of Tumor Vasculature /$rJ. Wilson, David C. West and Philip E. Thorpe.$g25.$tEndothelial Monocyte-Activating Polypeptide II: A Novel Injury Signal? /$rCliff Murray and Maarten Tas.
505 80 $g26.$tCD 105 Antibody for Targeting of Tumor Vascular Endothelial Cells /$rBen K. Seon and Shant Kumar --$gVI.$tAngiotherapy in the Clinic.$g27.$tDesign of Pharmacological and Diagnostic Strategies for Angiogenesis-Dependent Diseases /$rLucia Morbidelli and Marina Ziche.$g28.$tDesign of Clinical Trials for Anti-Angiogenics /$rElise C. Kohn.$g29.$tAngiogeneis Therapies: Concepts, Clinical Trials, and Considerations for New Drug Development /$rWilliam W. Li, Vincent W. Li and Dimitris Tsakayannis.$g30.$tAngiostatin and Endostatin: Recent Advances in Their Biology, Pharmacokinetics, and Potential Clinical Applications /$rJesus V. Soriano and B. Kim Lee Sim.
650 12 $aNeovascularization, Pathologic.$0https://id.nlm.nih.gov/mesh/D009389
650 22 $aNeovascularization, Physiologic.$0https://id.nlm.nih.gov/mesh/D018919
700 1 $aFan, Tai-Ping D.$0http://id.loc.gov/authorities/names/n93801386
700 1 $aKohn, Elise C.$0http://id.loc.gov/authorities/names/n00123163
852 00 $boff,hsl$hQP106.6$i.N49 2002